| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | President and CEO, Director | Common Stock | 175 K | $6.85 M | $39.22 | Mar 19, 2024 | Direct |
| RHYTHM PHARMACEUTICALS, INC. | President and CEO, Director | Restricted Stock Units | 85 K | $4.25 M | $50.01 | Feb 16, 2024 | Direct |
| RHYTHM PHARMACEUTICALS, INC. | President and CEO, Director | Stock Option (Right to Buy) | 259 K | Feb 16, 2024 | Direct | ||
| Trevi Therapeutics, Inc. | Director | Nonstatutory Stock Option (right to buy) | 30 K | Jun 13, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| TRVI | Trevi Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Mar 19, 2024 | 1 | -$1.78 M | 4 | Mar 19, 2024 | President and CEO, Director |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Feb 16, 2024 | 3 | $0 | 4 | Feb 21, 2024 | President and CEO, Director |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Feb 1, 2024 | 3 | -$197 K | 4 | Feb 5, 2024 | President and CEO, Director |
| TRVI | Trevi Therapeutics, Inc. | Jun 28, 2023 | 1 | $0 | 4 | Jun 30, 2023 | Director |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Feb 1, 2023 | 2 | $0 | 4 | Feb 3, 2023 | President and CEO, Director |
| TRVI | Trevi Therapeutics, Inc. | Jun 23, 2022 | 1 | $0 | 4/A | Jul 1, 2022 | Director |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Feb 9, 2022 | 1 | $0 | 4 | Feb 11, 2022 | President and CEO, Director |
| TRVI | Trevi Therapeutics, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |